phagos
Company
|
France, Paris
Primary tabs
About your organization / profile
- phagos deploys a solution to fight the antibiotic resistance pandemic - starting in its biggest contributor, animal farming.
- We built an ML-driven bio platform unlocking unprecedented bacteriophage efficiency and are 10x faster than competitors to deliver. Clinical trials show up to +70% health improvements when using our solutions.
- Two billion-$ multinationals have already chosen phagos to replace their antibiotics. Our deal pipeline has a €65m ARR potential, including a signed contract with a €7.5m ARR potential. Commercialisation starts by year end.
We’re raising €15m to deploy our current deal pipeline and further expand it to a €250m ARR potential. - €10m+ are already committed by existing investors Hoxton and Demeter + followers.
You'll find our teaser on this link.
password: wordofmouth
I'd be happy to tell you more over a call! Please don't hesitate to book me on this link.
Network (0)
There are no organizations in the network.
Recent activities
phagos is now a member of the EIC ACCESS+ community.
phagos has taken its fundraising offline.
phagos is now a member of the EEN2EIC - Seal of Excellence community.
The pitchdeck document has been updated in the dataroom.
phagos has published fundraising documents.
Alexandros Pantalis has joined phagos.